Press "Enter" to skip to content

Top medical journals accused of skewing research by raking in millions of dollars in ‘bribes’ from drugs firms

Top medical journals accused of skewing research by raking in millions of dollars in ‘bribes’ from drugs firms

Several of the top medical journals in the US have found to be raking in millions of dollars from pharmaceutical companies, a practice that calls the reliability of those journals into question.  
Nearly two thirds of medical research in the US is underwritten by companies, totaling more than $100 billion annually.  
This is potentially problematic because companies have a financial stake in study results and thus could have an incentive to publicly report results that put them in a favorable light and conceal less flattering findings.  
Reports have revealed that many top medical journals may be financially motivated to publish the studies that are unfairly skewed in favor of drug firms both through printing fees and payments to journal editors.  
Journals profiting the most from their relationships with drug firms included the journal for the American Medical Association (JAMA), which gets 52 percent of its revenue from printing studies by pharmaceutical companies, and the journal for the American College of Cardiology (JACC), whose 35 editors rake in an estimated $15 million from companies each year.

Source: Top medical journals accused of skewing research by raking in millions of dollars in ‘bribes’ from drugs firms

Leave a Reply

Specify a Disqus shortname at Social Comments options page in admin panel
Mission News Theme by Compete Themes.